Pharma-to-patient info plans ‘buried alive’ by nervous EU nations
This article was originally published in Scrip
Executive Summary
Controversial plans to give the pharmaceutical industry in the EU some sort of a role in providing information to patients on prescription drugs have reached the end of the line after opposition from the member states led to the draft legislation being abandoned.